- Home
- ENS vs ACLX Comparison
ENS vs ACLX Comparison
Compare ENS & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ENS | ACLX |
|---|---|---|
| Founded | 1991 | 2015 |
| Country | United States | United States |
| Employees | 9200 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 6.7B |
| IPO Year | 2004 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ENS | ACLX |
|---|---|---|
| Price | $222.03 | $115.08 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 15 |
| Target Price | ★ $193.00 | $118.17 |
| AVG Volume (30 Days) | 268.5K | ★ 3.3M |
| Earning Date | 05-20-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.51% | N/A |
| EPS Growth | ★ 38.31 | N/A |
| EPS | ★ 5.65 | N/A |
| Revenue | ★ $216,125,000.00 | $22,286,000.00 |
| Revenue This Year | $4.49 | $342.39 |
| Revenue Next Year | $3.41 | $170.71 |
| P/E Ratio | $38.34 | ★ N/A |
| Revenue Growth | ★ 15.85 | N/A |
| 52 Week Low | $76.60 | $60.36 |
| 52 Week High | $239.69 | $115.14 |
Technical Indicators
Market Signals| Indicator | ENS | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 56.21 | 79.86 |
| Support Level | $152.19 | $63.46 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 7.38 | 0.11 |
| MACD | -1.79 | -0.62 |
| Stochastic Oscillator | 44.39 | 84.28 |
Price Performance
Historical ComparisonAbout ENS EnerSys
EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.